Pharmaceutical composition for oral administration, based on a diphosphonic acid derivative
US4980171A · kind A · utility
26Cited by
5References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 6, 1989 |
| Grant date | Dec 25, 1990 |
| Priority date | — |
| Expiry date | Apr 6, 2009 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to oral pharmaceutical compositions comprising a diphosphonic acid derivative and sodium laurylsulfate in the amount of 1.5 to 6% by weight, relative to the diphosphonic compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.